Virginia Retirement Systems Et Al Cerus Corp Transaction History

Virginia Retirement Systems Et Al

  • $10.1 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jul 11, 2023
BUY
$2.65 - $3.81 $56,975 - $81,915
21,500 Added 57.18%
59,100 $175,000
Q4 2022

May 17, 2023
BUY
$3.38 - $4.22 $50,362 - $62,877
14,900 Added 65.64%
37,600 $137 Million
Q3 2022

May 16, 2023
BUY
$3.43 - $5.83 $77,861 - $132,341
22,700 New
22,700 $81.7 Million

Others Institutions Holding CERS

# of Institutions
157
Shares Held
148M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $321M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email